La acción de grupo : mecanismo adecuado y efectivo para reparar graves violaciones a los derechos humanos

La presente tesis, demuestra que la acción de grupo, consagrada en el Artículo 88 de la Constitución Política de Colombia y en la Ley 472 de 1998, es un mecanismo idóneo y efectivo de reparación en casos de graves violaciones a los derechos humanos v.gr. desplazamiento forzado. Para ello, en una primera parte, se presentan algunos antecedentes internacionales de esta acción, como lo son los International Mass Claims Processes y las Class Actions anglosajonas, que evidencian los casos de procedencia y los requisitos que se han establecido a nivel internacional para que una acción colectiva pueda proceder para indemnizar esta clase de violaciones. Posteriormente, en una segunda parte, se analizan los principales aspectos procesales de la acción de grupo, como lo son, por ejemplo, la conformación del grupo, la representatividad adecuada, el termino de caducidad de la acción, la notificación de la demanda, la publicación de la sentencia y el estimativo de perjuicios, entre otros aspectos, que a nivel sustancial y procedimental muestran que la acción de grupo es un mecanismo adecuado para indemnizar in integrum a las víctimas de las graves violaciones a los derechos humanos. Por último, se establece que el estándar internacional de reparación que es empleado en el sistema interamericano de protección de derechos humanos (Restitución, indemnización. rehabilitación, satisfacción, garantía de no repetición y proyecto de vida) puede ser aplicado de manera adecuada y efectiva a través del empleo de la acción de grupo.

The use of insect cells to identify potent and selective inhibitors of the replication of the Dengue and Chikungunya viruses and unravel their molecular mechanism of action

Dengue and Chikungunya viruses cause the most important arthropod-borne viral infections for humans. These viruses are predominant in tropical and subtropical regions. In addition, these viruses are predominant in tropical and subtropical regions. Dengue mortality rate is around 1.2 to 3.5% and deaths due to chikungunya fever are around 1 in 1000; however, half of chikungunya-infected patients evolve into a chronic state that can persist for months up to years. There are no antiviral drugs available for DENV and CHIKV treatment and prevention. Moreover, vector control strategies have failed so far. Thus, the development of potent inhibitors for a broad spectrum of RNA viruses is urgently needed. We established and characterized a new embryonic insect cell line from Culex quinquefasciatus mosquito. Also we established the flaviviruses and alphavirus replication, both in C6/36 and Lulo insect cell lines, as well as in Vero cell line. In addition we carried out a reference compound library and reference panel of assays and data for DENV, which provides a benchmark for further studies. During this study, a panel of 9 antiviral molecules, with proven in vitro anti-dengue virus activity and that act at different stages of the DENV life cycle, was selected. Finally, Favipiravir or T-705, was identified as inhibitor in vitro and in vivo of alphaviruses and the mutation K291R in nsP4, which is responsible of the polymerase activity, was found as the mode of action in CHIKV. Interestingly, lysine in motif F1 is also highly conserved in positive-stranded RNA viruses and this might explain the broad spectrum of T-705 antiviral activity.

Testing for Hidden Information and Action in Automobile Insurance Market

I test the presence of hidden information and action in the automobile insurance market using a data set from several Colombian insurers. To identify the presence of hidden information I find a common knowledge variable providing information on policyholder s risk type which is related to both experienced risk and insurance demand and that was excluded from the pricing mechanism. Such unused variable is the record of policyholder s traffic offenses. I find evidence of adverse selection in six of the nine insurance companies for which the test is performed. From the point of view of hidden action I develop a dynamic model of effort in accident prevention given an insurance contract with bonus experience rating scheme and I show that individual accident probability decreases with previous accidents. This result brings a testable implication for the empirical identification of hidden action and based on that result I estimate an econometric model of the time spans between the purchase of the insurance and the first claim, between the first claim and the second one, and so on. I find strong evidence on the existence of unobserved heterogeneity that deceives the testable implication. Once the unobserved heterogeneity is controlled, I find conclusive statistical grounds supporting the presence of moral hazard in the Colombian insurance market.